Aurobindo Pharma announces two senior management departures

Hyderabad, India – Aurobindo Pharma Limited announced the departure of two senior management personnel effective November 2025. Dr. Mandepudi Sudhakara Reddy, associate president, corporate QA, tendered his resignation on August 9, 2025, with his last day of employment being November 4, 2025.

Additionally, Mr. K. P. Ravinatha Shetty, president, operations, retired from the company's services on November 3, 2025, upon attaining superannuation. Both changes were disclosed in compliance with Regulation 30 of the SEBI Listing Regulations.

These personnel changes are effective close of business hours on November 4, 2025, for Dr. Reddy, and November 4, 2025, for Mr. Shetty's relief from services.